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Abstract
Background: Recently, a cutaneous force-frequency relation recording system based on first
heart sound amplitude vibrations has been validated. A further application is the assessment of
Second Heart Sound (S2) amplitude variations at increasing heart rates. The aim of this study was
to assess the relationship between second heart sound amplitude variations at increasing heart
rates and hemodynamic changes.
Methods:  The transcutaneous force sensor was positioned in the precordial region in 146
consecutive patients referred for exercise (n = 99), dipyridamole (n = 41), or pacing stress (n = 6).
The curve of S2 peak amplitude variation as a function of heart rate was computed as the increment
with respect to the resting value.
Results: A consistent S2 signal was obtained in all patients. Baseline S2 was 7.2 ± 3.3 mg, increasing
to 12.7 ± 7.7 mg at peak stress. S2 percentage increase was + 133 ± 104% in the 99 exercise, + 2
± 22% in the 41 dipyridamole, and + 31 ± 27% in the 6 pacing patients (p < 0.05). Significant
determinants of S2 amplitude were blood pressure, heart rate, and cardiac index with best
correlation (R = .57) for mean pressure.
Conclusion: S2 recording quantitatively documents systemic pressure changes.
Introduction
Recently, a cutaneous operator independent force-fre-
quency relation recording system as been validated in the
stress echo lab, based on first heart sound amplitude var-
iations at increasing heart rates [1,2]. Contractility quanti-
fication and systolic/diastolic time measurement through
the system has been previously demonstrated [1,3]. A fur-
ther application could be the assessment of Second Heart
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Sound (S2) amplitude variations at increasing heart rates.
In fact, the maximum amplitude of vibrations measured
by the sensor following the ECG T wave originates from
the physical phenomenon of the abrupt deceleration of
the moving aortic blood mass. The audible components
of this deceleration give rise to the Second Heart Sound
(S2) [4-6]. The aim of this study was to assess the relation-
ship between second heart sound amplitude variations at
increasing heart rates and hemodynamic changes.
Methods
Patient selection
We enrolled 146 consecutive patients (99 males, 60 ± 14
years) referred for stress echocardiography. Patients' char-
acteristics are summarized in Table 1. The type of stressor
was chosen by the attending cardiologist/echocardiogra-
phist at time of testing in relation to relative contraindica-
tions of one stressor over the other [7,8]. Ninety-nine
subjects underwent exercise stress (13 non competitive
athletes were the controls). Twenty-four patients unable
to exercise and 17 patients scheduled for coronary flow
reserve evaluation underwent dipyridamole stress echo.
Six patients with permanent pace maker (DDD in 5, BIV
in 1) underwent pacing stress. Coronary artery disease was
defined by the presence of angiographically assessed cor-
onary stenosis (with quantitatively assessed diameter
reduction in major coronary vessels) or previous myocar-
dial infarction. The local Ethical Committee approved the
study protocol. All patients gave their written informed
consent before entering the study. All patients met the fol-
lowing inclusion criteria: 1) referred to stress echo for clin-
ically-driven testing. 2) acoustic window of acceptable
quality 3) willingness to enter the study. From the initially
considered population of 152 patients, 4 were excluded
for poor acoustic window (n = 4), or refusal to give written
informed consent (n = 2).
Semi-supine bicycle exercise
Graded bicycle semi-supine exercise echo was performed
starting at an initial workload of 25 watts lasting for 2
minutes; thereafter the workload was increased stepwise
by 25 watts at 2 minutes interval. A 12-lead electrocardio-
gram and blood pressure determination were performed
at baseline and every minute thereafter [7]. Two-dimen-
sional echocardiographic monitoring was performed
throughout and up to 5 min after the end of peak stress.
Two-dimensional images were recorded at baseline and at
the end of each step.
Dipyridamole stress echo
Two-dimensional echocardiography and 12-lead electro-
cardiographic (ECG) monitoring were performed in com-
bination with high dose dipyridamole (up to 0.84 mg
over 6 min) in accordance to well established protocols
[7,8]. Contraindications to using dipyridamole were
asthma, hypotension, and bradyarrhythmias.
Pacing stress echo
The pacing protocol was accelerated (with a 10-beat incre-
ment every 60 s) until one of the following criteria was
reached: 1 – 85% of maximal heart rate (age-corrected:
220 – age for men, 200 – age for women); or 2 – PM max-
imal programmable heart rate (which varied widely,
according to the model of PM, up to 170 bpm during
stress). Stimulation was performed, wherever possible, in
atrial stimulation mode, or dual-chamber (DDD) pacing
to have normal contraction sequence [9].
Regional wall motion analysis
Regional wall motion analysis was evaluated at baseline
and at peak stress with a semiquantitative assessment of a
wall motion score index (WMSI), with the 17 segment
model of the left ventricle, each segment ranging from 1 =
normal/hyperkinetic to 4 = dyskinetic, according to the
recommendations of the American Heart Association and
American Society of Echocardiography. WMSI was
derived by dividing the sum of individual segment scores
by the number of interpretable segments [8,10]. Test pos-
itivity was defined as the occurrence of at least one of the
following conditions: 1) new dyssynergy in a region with
normal rest function (i.e., normokinesia becoming hypo-
kinesia, akinesia or dyskinesia) in at least two adjacent
segments.
Diagnostic end points and interruption criteria
The diagnostic end-points for all types of stress were: the
development of obvious echocardiography positivity.
Non-echocardiographic test end-points were the follow-
ing: peak dipyridamole dose; 85% of target heart rate;
achievement of conventional end-points (such as severe
chest pain and/or diagnostic ST segment changes). The
test was also stopped, in the absence of diagnostic end-
points, for one of the following reasons of constituting a
submaximal, non-diagnostic test: intolerable symptoms;
limiting asymptomatic side effects, consisting of: a)
Table 1: Characteristics of the study patients
EXERCISE DIP PACING
Pt n° 99 41 6
Age (years) 56 ± 14 68 ± 11 68 ± 10
Males 68 27 4
Controls 13 - -
CAD 36 29 3
Previous PTCA/By pass 27 19 1
Previous myocardial infarction 25 13 2
Arterial hypertension 18 5 -
Valvular disease 19 2 1
Atipical chest pain 12 3 1
DCM 1 2 1Cardiovascular Ultrasound 2008, 6:41 http://www.cardiovascularultrasound.com/content/6/1/41
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hypertension (systolic blood pressure >220 mmHg;
diastolic blood pressure >120 mmHg); b) hypotension
(relative or absolute): >30 mmHg fall of blood pressure;
c) supraventricular arrhythmias: supraventricular tachy-
cardia or atrial fibrillation; d) ventricular arrhythmias:
ventricular tachycardia; frequent, polymorphous prema-
ture ventricular beats [8].
Blood pressure analysis
One nurse recorded blood pressures at rest and during
each individual study. The blood pressure recording was
made using a sphygmomanometer and the diaphragm of
a standard stethoscope. Systolic and diastolic blood pres-
sure was obtained in the right arm. During exercise test,
blood pressure recording was obtained with patient lying
in a left rotated semi supine position and instructed to
hand grip to the left support with their left hand. Patients
have been told to let their right hand go limp when blood
pressure was measured.
By selection, 75 out of the 99 patients of the exercise
group had simultaneous S2 amplitude and systemic
blood pressure measurement at the first, third and fifth
post exercise minute time.
Volume analysis
All patients underwent transthoracic echocardiography at
baseline and during stress. Left ventricular end-diastolic
and end-systolic volumes were measured from apical
four- and two-chamber view, by an experienced observer
using the biplane Simpson-method. Only representative
cycles with optimal endocardial visualization were meas-
ured and the average of three measurements was taken.
The endocardial border was traced, excluding the papil-
lary muscles. The frame captured at the R wave of the ECG
was considered to be the end-diastolic frame, and the
frame with the smallest left ventricular cavity the end
systolic frame. Images were acquired at baseline and at
each increase in heart rate of 10 beats during stress.
Systemic Vascular Resistance (SVR)
SVR were calculated according to the traditional formula:
SVR = 80 * (MAP-5)/CO,
where 5 is an approximation of the right atrial pressure
and MAP is mean arterial pressure.
Systemic arterial compliance
Systemic arterial compliance (C) was calculated as stroke
volume index/systemic arterial pulse pressure; were pulse
pressure = systolic blood pressure – diastolic blood pres-
sure [11].
Arterial elastance and ventricular-arterial coupling
In all, ventricular arterial coupling was indexed by the
ratio of left ventricular systolic elastance index (systolic
pressure/end-systolic volume index) to arterial elastance
(Ea, ratio of end-systolic pressure by stroke volume).
Echocardiography (for ESV and stroke volume) and cuff
sphygmomanometer (systolic pressure, multiplied × 0.90
to obtain end-systolic pressure) provided the raw meas-
urements.
Because stroke volume (and input impedance) varies
directly with body size, arterial elastance was adjusted for
body surface area (EaI) to better reflect differences in arte-
rial properties with age and between the genders adjusted
for differences in body size [12]. Of note ventricular-arte-
rial coupling is ventricular elastance/arterial elastance,
which can further be described as: end-systolic pressure/
end-systolic LV volume divided by end-systolic pressure/
stroke volume: the pressure terms in the numerator and
the denominator cancel out, and ventricular-arterial cou-
pling equals to stroke volume/end-systolic volume.
Operator-independent second heart sound quantification
The transcutaneous force sensor is based on a linear accel-
erometer from STMicroelectronics (LIS3). The device
includes in one single package a MEMS sensor that meas-
ures a capacitance variation in response to movement or
inclination and a factory trimmed interface chip that con-
verts the capacitance variations into analog signal propor-
tional to the motion. The device has a full scale of ± 2·g
(g = 9.8 m/s2) with a resolution of 0.0005·g. We housed
the device in a small case (Figure 1) which was positioned
in the mid-sternal precordial region and was fastened by a
solid gel ECG electrode. The acceleration signal was con-
verted to digital and recorded by a laptop PC, together
with an ECG signal. The system is also provided with a
user interface that shows both the acceleration and the
ECG signals while the acquisition is in progress[1]. The
data were analyzed by using software developed in Matlab
(The MathWorks, Inc). A peak detection algorithm, syn-
chronized with the ECG, scans the first 150 ms following
the R wave to locate the first heart sound vibration. Subse-
quently, the interval between the first heart sound and the
following R wave is analyzed to record the amplitude
(nadir to peak) of second heart sound vibration for each
cardiac beat [3]. The accelerometer simply records natu-
rally generated heart vibrations, which audible compo-
nents give rise to the second heart sound 'See additional
file 1: Appendix'.
The curve of S2 peak amplitude variation as a function of
heart rate was finally computed as the increment with
respect to the resting amplitude value [13]. All the param-
eters were acquired as instantaneous values at baseline
and during stress; mobile mean was utilized to assessCardiovascular Ultrasound 2008, 6:41 http://www.cardiovascularultrasound.com/content/6/1/41
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baseline value (1 minute recording), at each incremental
stress test, at peak test, and during recovery (Figure 2).
Baseline, peak stress, peak-rest difference as absolute
value, and delta % rest-peak stress values were computed.
Non myocardial noising vibrations (skeletal muscles,
body movements, breathing) were eliminated by fre-
quency filtering.
Statistical analysis
SPSS 11 for Windows was utilized for statistical analysis.
The statistical analyses included descriptive statistics (fre-
Isovolumic contraction force and second heart sound (S2) amplitude Figure 1
Isovolumic contraction force and second heart sound (S2) amplitude. A Micro-Electro-Mechanical Systems (MEMS) 
accelerometer is temporarily positioned in the mid-sternal precordial region before starting the scheduled stress test in all 
patients. A peak detection algorithm, synchronized with the ECG, scans the first 150 ms following the R wave to record the 
isovolumic contraction force vibration and then the interval before the following R wave to record the second heart sound 
amplitude (S2, pink symbol). All the parameters are acquired as instantaneous values at baseline and during stress. The data can 
be also read remotely by a wireless bluetooth sensor network, with reliable continuous remote monitoring 'See additional file 
1: Appendix'.
Computing the second heart sound amplitude variation as a function of heart rate Figure 2
Computing the second heart sound amplitude variation as a function of heart rate. All the parameters are acquired 
as instantaneous values at baseline and during stress; mobile mean is utilized to assess baseline value (1 minute recording), at 
each incremental stress test, at peak test, and during recovery. Left panel: instantaneous S2 amplitude scattering (blue points 
exercise, red points recovery) depends on the respiratory cycle and thorax expansion; blue and red curves = S2 amplitude 
mobile mean. Right panel: blue curve = exercise in progress; red curve = recovery.Cardiovascular Ultrasound 2008, 6:41 http://www.cardiovascularultrasound.com/content/6/1/41
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quency and percentage of categorical variables and mean
and standard deviation of continuous variables).
The one-way ANOVA was used to compare continuous
variables between groups; when homogeneity of variance
was not present, the Kruskal-Wallis test for nonparametric
independent samples was used. Intergroup comparison
was performed with Scheffe and Tamhane post hoc tests,
respectively.
Relations between variables were assessed using linear
regression analysis and Pearson's correlation coefficient.
Cardiac or vascular properties significantly related to the
S2 amplitude changes were graphically displayed with
simple scatter plots. Crosstabs' statistics and measures of
association for post exercise hypotension vs. post exercise
S2 amplitude undershoot were performed in 75 selected
patients.
Results
Resting and stress echocardiographic findings
Technically adequate images were obtained in all patients
at baseline (by selection) and during stress.
At Peak Exercise
Heart rate was lower in the dipyridamole than in the exer-
cise and pacing groups. The mean ejection fraction
increased in the exercise and Dip groups, while decreased
in the pacing group. Regional wall motion abnormalities
occurred in 5 patients of the exercise, 1 patient of Dip and
2 patients of the pacing groups (Table 2).
Peripheral pressures, load and coupling
Arterial elastance increased in the exercise and the Pacing
groups, while decreased in the dipyridamole, mainly due
to a greater dipyridamole induced arterial compliance
(Table 2).
Despite similar baseline values, diastolic blood pressure
increased in the exercise, decreased in the dipyridamole,
while unchanged in the pacing group, although the
response was heterogeneous at the individual level (Table
2).
Sensor built second heart sound amplitude variations
A consistent second heart sound signal was obtained in all
patients at rest and during stress (Figure 2). In the patients
as a whole, baseline S2 was 7.2 ± 3.3 mg, increasing to
12.7 ± 7.7 mg at peak stress. S2 trends during exercise or
dipyridamole are shown in Figure 3.
Mean S2 percentage increase was + 133 ± 104% in the 99
exercise patients, + 2 ± 22% in the 41 dipyridamole
patients and + 31 ± 27% in the 6 pacing patients (p < 0.05
between groups) (Table 2).
In the exercise group the S2 amplitude percentage increase
was similar in the 13 control and in the 86 patients (+ 140
± 123% vs. 132 ± 102%, p = ns)
At linear regression analysis significant positive determi-
nants of the S2 amplitude changes during stress were the
systemic blood pressure, the heart rate, and cardiac index
rest-peak changes (Table 3). Scatter plots demonstrating
correlations between S2 changes and arterial pressure rest-
peak changes are displayed in Figure 4.
Second heart sound undershoot and the post exercise 
hypotension
A significant correlation was found between post exercise
hypotension and recovery S2 undershoot: 44 (80%) of the
55 patients with post-exercise hypotension had S2 under-
shoot in the recovery, while 19 (96%) of the 20 patients
without post-exercise hypotension had stable rate-S2
curve at recovery (Table 4) (Figure 3).
Discussion
A stable, reproducible, and consistent S2 force signal was
recorded in all patients at rest and during stress. Baseline
force value had an ample range (from 2 to 23 g * 10-3).
The most widely accepted theory for the genesis of the sec-
ond heart sound is the "cardiohemic model," which states
that the sounds are produced by the vibration of the entire
heart and its contents [14]. This vibration is triggered by
valve closure (the aortic and pulmonary valves for the sec-
ond heart sound). The amplitude of these sounds
depends on the force with which the valves close, which,
in turn, depends on the pressure gradient across the valve
at the time of closure. We previously demonstrated that in
adult patients undergoing stress testing, the first heart
sound amplitude was directly related to myocardial con-
tractility [1]. In this investigation, blood pressure (systo-
lic, diastolic and mean) correlated closely with S2
amplitude. This may be explained by the fact that ampli-
tude is primarily determined by one factor, the force of
valve closure [15].
Biophysics of the second heart sound
Early studies of the hemodynamic determinants of the
amplitude of the S2 have related the aortic component
amplitude of the S2 vibration to the aortic pressure, in
agreement with clinical findings that hypertensive
patients frequently have loud second heart sounds
[4,16,17]. In their proposed mechanism for the origin of
the second heart sound, Sabbah and Stein [6] showed a
relation between the amplitude of S2 and the driving pres-
sure. Driving pressure, in the heart, refers to the instanta-
neous difference between arterial and ventricular pressure
shortly after semilunar closure. Kusukawa and associates
[5] previously found a good correlation of the amplitude
of the second heart sound with the difference of pressureCardiovascular Ultrasound 2008, 6:41 http://www.cardiovascularultrasound.com/content/6/1/41
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between the aorta and the left ventricle coincident with
the dicrotic notch. But patients suffering from myocardial
infarction and/or heart failure, often exhibit reduced S2
amplitude, even when the aortic pressure is normal [18].
They showed that the amplitude of S2 was linearly related
to the rate of change of the pressure gradient that develops
across the aortic valve during diastole (r = .82). The latter
is also correlated with negative dP/dt (r = .62).
In normotensive patients with poor ventricular perform-
ance, the rate of isovolumic relaxation may be compro-
mised and this would cause a reduction in negative dP/dt
which in turn causes a reduction of the rate of change of
the pressure gradient that develops across the valve during
diastole. A diminished S2, therefore, would result due to
the more slowly developing driving pressure, which
directly affects the characteristics of valvular vibration.
Table 2: Rest and stress data
EXERCISE DIP PACING
N of pts 99 41 6
Age (yrs) 56 ± 14 § 68 ± 11 68 ± 10
Gender (M/F) 68/31 27/14 4/2
BSA (m2) 1.88 ± .19 1.83 ± .16 1.87 ± .28
Standard echo measurements
LVMI (g/m2) 104 ± 28 104 ± 20 138 ± 34
HR rest (bpm) 73 ± 16 66 ± 13 71 ± 10
HR peak (bpm) 131 ± 24 Δ 84 ± 13 * 132 ± 13
LV EF % rest 59 ± 11 58 ± 13 51 ± 11
LV EF % peak 67 ± 14 ‡ 62 ± 13 * 45 ± 16
WMSI rest 1.11 ± .29 1.17 ± .32 1.28 ± .46
WMSI peak 1.13 ± .31 1.19 ± .32 1.4 ± .46
Δ WMSI (rest-peak) .02 ± .10 .01 ± .07 .15 ± .24
Sensor built second heart sound (S2) amplitude changes
S2 rest (mg) 7.7 ± 4.9 7.1 ± 2.8 5.8 ± 1.4
S2 peak (mg) 15.9 ± 8.7 § 7.2 ± 3 7.7 ± 2.4
S2 Δ rest-peak (mg) 8.2 ± 6.1 § .1 ± 1.5 1.8 ± 1.9
S2 Δ % (rest-peak) 133 ± 104 § 2 ± 22 31 ± 27
Perpheral pressures, load and coupling
SBP rest (mmHg) 134 ± 21 137 ± 20 131 ± 25
SBP peak (mmHg) 189 ± 26 § 127 ± 26 137 ± 37
Δ SBP (rest-peak, mmHg) 55 ± 25 § -8 ± 17 6 ± 17
DBP rest (mmHg) 74 ± 12 71 ± 12 74 ± 11
DBP peak (mmHg) 94 ± 13 § 67 ± 13 75 ± 15
Δ DBP (rest-peak, mmHg) 20 ± 13 § -4 ± 10 1 ± 15
Mean pressure rest (mmHg) 94 ± 13 93 ± 12 93 ± 14
Mean pressure peak (mmHg) 126 ± 15 § 88 ± 17 96 ± 20
Δ mean pressure (rest-peak, mmHg) 32 ± 14 § -5 ± 12 2 ± 15
SVR rest (dyne * sec * cm-5) 2134 ± 802 2118 ± 702 1652 ± 533
SVR peak (dyne * sec * cm-5) 1501 ± 547 1551 ± 747 1546 ± 620
Δ SVR (rest-peak, dyne * sec * cm-5) -632 ± 669 ‡ -567 ± 613 -106 ± 382
Arterial compliance rest (mL *m-2/mmHg) 0.49 ± 0.18 0.48 ± 0.2 0.7 ± 0.38
Arterial compliance peak (mL *m-2/mmHg) 0.33 ± 0.11 Δ 0.55 ± 0.22 0.4 ± 0.2
Δ Arterial compliance (rest-peak, mL *m-2/mmHg) -0.17 ± 0.17 Δ 0.07 ± 0.15 * -0.3 ± 0.24
Arterial elastance index rest (mmHg/mL/m2) 4.7 ± 1.5 4.5 ± 1.5 3.6 ± 1.1
Arterial elastance index peak (mmHg/mL/m2) 6.2 ± 1.8 Δ 4.1 ± 1.1 * 6.3 ± 2.5
Δ Arterial elastance index (rest-peak, mmHg/mL/m2) 1.5 ± 1.6 Δ -.4 ± 1.4 * 2.7 ± 1.7
Ventricular/arterial coupling rest (SP/ESV/EaI ratio) 1.8 ± .9 1.8 ± .9 1.3 ± .7
Ventricular/arterial coupling peak (SP/ESV/EaI ratio) 2.9 ± 1.9 § 2.1 ± 1.1 1.1 ± .8
Δ Ventricular/arterial coupling (rest-peak) 1.1 ± 1.6 § .4 ± .6 -0.2 ± .4
Cardiac index rest (L/min/m2) 2 ± 0.7 1.9 ± 0.5 2.5 ± 0.7
Cardiac index peak (L/min/m2) 3.9 ± 1.3 § 2.7 ± 0.9 2.7 ± 0.8
Δ Cardiac index (rest-peak, L/min/m2) 1.9 ± 1.2 § 0.7 ± 0.6 0.3 ± 0.5
§= significant differences between exercise and both dipyridamole and pacing stress pts; ‡ = significant differences between exercise and pacing 
stress pts; * = significant differences between dipyridamole and pacing stress pts; Δ = significant differences between exercise and dipyridamole 
stress ptsCardiovascular Ultrasound 2008, 6:41 http://www.cardiovascularultrasound.com/content/6/1/41
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Tanigawa et al [4] demonstrated in instrumented dogs,
that when the time constant of left ventricular pressure fall
"T" was normal, the aortic systolic pressure and diastolic
pressure were good predictors of S2 intensity. When LV
relaxation was impaired, increasing T greater than 135%
of control, the S2 intensity for any given aortic pressure
was reduced. When relaxation was hyperactive, decreasing
T less than 65% of control, S2 intensity was increased.
Aortic pressure/T which assessed both aortic pressure and
relaxation ability, is a better determinant of A2 intensity
Second heart sound (S2) amplitude recording simultaneously with diastolic blood pressure during stress Figure 3
Second heart sound (S2) amplitude recording simultaneously with diastolic blood pressure during stress. Left 
panel: similar S2-frequency trend during stress (blue symbols) and recovery (red symbols) in a patient with normal exercise 
pressure changes and without post exercise hypotension. Middle panel: S2-frequency trend during stress (blue symbols) and 
recovery (red symbols) in a patient with exercise induced diastolic hypertension and post exercise hypotension. Right panel: 
flat-negative S2-frequency trend during dipyridamole stress induced hypotension.
Table 3: Significant determinants of the sensor second heart sound (S2) amplitude values
Rest S2 Peak S2 S2 Δ % rest-peak
Age (yrs) -.359 (<.01) -.476 (<.01) -.153 (<.05)
BSA (m2)
LVMI (g/m2) -.194 (<.05)
LV EF % .215 (<.01)
WMSI
HR (bpm) .206 (<.01) .516 (<.01) .453 (<.01)
Diastolic Blood Pressure (mmHg) .183 (<.05) .319 (<.01) .502 (<.01)
Systolic Blood Pressure (mmHg) .338 (<.01) .544 (<.01)
Mean Blood Pressure (mmHg) .345 (<.01) .567 (<.01)
Ventricular elastance (mmHg/mL/m2) .144 (<.05) .218 (<.01)
Arterial elastance .307 (<.01) .281 (<.01)
SVR (dyne * sec * cm-5)
Arterial compliance (mL *m-2/mmHg) -.340 (<.01) -.300 (<.01)
Ventricular/arterial coupling
Cardiac index .153 (<.05) .432 (<.01) .388 (<.01)
Linear regression analysis to identify significant relationship between predictor variables (first column) and the sensor second heart sound (S2) 
amplitude was performed for baseline (second column) peak stress (third column) and rest-peak delta values (fourth column).
Pearson's correlation coefficients (and significance value within brackets) are reported in cells with significant (p < 0.05) relationships.Cardiovascular Ultrasound 2008, 6:41 http://www.cardiovascularultrasound.com/content/6/1/41
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than aortic systolic pressure or aortic diastolic pressure
alone.
Second heart sound frequencies or amplitude to get 
clinical information?
Previous studies have shown that it is possible to estimate
systemic blood pressure using the spectral information of
the second heart sound. A mathematical model for the
vibration of the closed aortic valve was proposed by
Zhang et al [19], showing that the increasing aortic pres-
sure results in an increase both in frequency and ampli-
tude of produced sound. The results of this study also
suggest that it is the increasing resonant frequency and
amplitude of the blood column induced by elevated dis-
tending pressure that plays significant role in the process.
Various mathematical methods have been used to
describe heart sounds, including the frequency domain
(FFT) and the time domain (RMS) amplitude.
The frequency domain (FFT)
The frequencies present in heart sounds are determined by
the volume of the vibrating mass (smaller volume has a
higher resonance frequency) and the tension generated in
the walls of the heart and great vessels. This explains the
fact that S2 is normally of higher frequency than S1 (the
aorta is of lower volume than the heart) and that younger
children exhibited higher heart sound frequencies than
older children [20]. Other Authors [21] stated that the
major concentration of energy, for both first heart sound
(M1) and second heart sound (S2), is below 150 Hertz
(Hz) which may indicate that both sounds are caused by
vibrations within the same structure, possibly the entire
heart. However S2 spectra have greater amplitude than S1
Second Heart sound recording quantitatively documents systemic pressure changes Figure 4
Second Heart sound recording quantitatively documents systemic pressure changes. Scatter plots demonstrating 
relationship between sensor Second Heart Sound amplitude % changes (y axis) and systemic pressure rest-peak changes values 
(x axis) in the whole group of 146 patients. Red symbols: exercise stress; green symbols: dipyridamole stress; blue symbols: 
pacing stress. Left panel: systolic pressure (SBP) changes. Middle panel: diastolic pressure (DBP) changes. Right panel: mean 
pressure (MP) changes.
Table 4: Crosstabs' statistics and measures of association for post exercise hypotension vs. post exercise second heart sound amplitude 
undershoot in 75 selected patients
Exercise recovery hypotension Exercise recovery isopressure Total
SHS Recovery Under shot 44 1 45
SHS Recovery same shot 11 19 30
Total 55 20 75
Kendall's tau-c = 0.591 P < 0.001Cardiovascular Ultrasound 2008, 6:41 http://www.cardiovascularultrasound.com/content/6/1/41
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spectra above 150 Hz, which may be due to vibrations
within the aorta and pulmonary artery. Because peak fre-
quency is a descriptor of only a single point, it is therefore
not a useful factor in describing heart sound changes
resulting from variations in myocardial contractility or
systemic pressure changes 'See additional file 1: Appen-
dix'.
The amplitude domain (RMS)
In previous investigation [20], hemodynamic variables
(heart rate and blood pressure) correlated more closely
with amplitude than with frequency. This may be
explained by the fact that amplitude is primarily deter-
mined by one factor – force of valve closure – whereas fre-
quency depends on the force of closure, heart volume,
and the resonance frequencies of the heart and great ves-
sels. Thus, differences in heart size and intravascular vol-
ume status could explain the greater variability (and, thus,
weaker statistical correlation) in frequency than ampli-
tude characteristics.
This is the motive for we used a peak amplitude (nadir to
peak) signal analysis system for both the first and the sec-
ond heart sounds vibrations [1,3].
The properties of the chest wall in the transmission of 
sound from inside the thorax to the surface of the chest
The chest wall is a low-pass filter. Cardiac vibrations prop-
agate as mechanical shear waves, and the intervening vis-
coelastic thoracic tissue attenuates the higher frequencies
and introduces a variable propagation delay [22,23].
In contrast to the dynamics observed epicardially, Wood
[24] demonstrated that heart sound frequency law was
dominated by quasi-stationary and impulse-like compo-
nents implying that the instantaneous power and the
power spectrum contain most of the diagnostic informa-
tion in heart sound.
Modelling the heart/thorax acoustic system in dogs, based
on the simultaneous recording of the intracardiac and
thoracic phonocardiograms, Durand and co-workers [25]
showed that the heart/thorax acoustic system acts like a
band pass filter having a higher attenuation for A2 than
for M1. Between 20 and 100 Hz, the mean attenuation of
M1 is 30 dB while that of A2 is 46 dB. Above 100 Hz, the
attenuation slope is -12 dB per octave for M1 and -6 dB
per octave for A2. Again, the frequency domain is influ-
enced by the heart/thorax acoustic system, and the fre-
quency based heart sound information is jeopardized by
a further variable. Using heart sound amplitude to get
clinical information, the absolute force value in the single
patient is certainly related to the transthoracic propaga-
tion of cardiac vibrations. In fact, when measured epicar-
dially or on the aortic root, S2 vibrations are up to 10
times more powerful than when measured on the chest,
and cannot be used as absolute value for interpatient com-
parison. However the amplitude (force) % changes (i.e.
contractility for M1 and systemic pressure for S2) are not
influenced by the heart/thorax acoustic system and the
data can be used for intrapatient changes as for contractil-
ity or systemic pressure changes.
Second heart sound and stress changes
Previous phonocardiography research has been focused
on the determination of heart sound production at rest,
but relatively little work has been done to investigate heart
sounds under stress testing. Luisada et al. [26] stated that
heart sound changes during stress may be more rapid and
sensitive than changes in heart rate and blood pressure. Of
the 146 study patients, 39 unchanged or decreased diasto-
lic blood pressure at peak stress vs. rest (mainly dipyrida-
mole group, 28 out of 41 pts) while 107 increased
diastolic blood pressure (mainly exercise group, 91 out of
99 pts). Patients with increased pressure had + 116 ±
106% second heart sound amplitude increase vs. + 26 ±
67% in patients with unchanged or decreased diastolic
blood pressure at peak stress. In our study, a mismatch
between increased diastolic pressure, but blunted S2
amplitude, occurred in 7 patients out of the 107 with
stress increased diastolic pressure. According to the physi-
ological basis, in these case the blunted S2 increase should
be related to a diminished driving pressure between the
aorta and the left ventricle, with delayed or altered active
LV relaxation. These 7 patients had coronary artery dis-
ease. Obviously, sensor measured S2 amplitude, without
ventricular relaxation data, blind us to the quantification
of the time constant of left ventricular pressure fall, and/
or to negative LV dP/dt. However, this totally noninvasive
sensor demonstrated capability to monitor beat to beat
systemic pressure changes, at rest and during exercise. Fur-
ther studies with simultaneous hemodynamic in humans
should be done to address this issue.
Second heart sound and post exercise hypotension
Post exercise hypotension has been demonstrated both in
hypertensive and healthy subjects [27] . In normotensive
subjects, it has been attributed to a decrease in cardiac out-
put and/or systemic vascular resistance [28,29]. Moreover,
it has been accompanied by a decrease in peripheral sym-
pathetic activity [29,30] and an increase in cardiac sympa-
thetic activity [31]. Other studies demonstrated that the
acute post-exercise reduction in blood pressure was clini-
cally similar following high intensity short duration exer-
cise and moderate intensity longer duration exercise [32].
Acute exercise may serve as a non-pharmacological aid in
the treatment of hypertension. S2 amplitude monitoring
could be a method to assess efficacy of the acute post-exer-
cise blood pressure reduction. In the selected patients of
our study, a significant correlation was found betweenCardiovascular Ultrasound 2008, 6:41 http://www.cardiovascularultrasound.com/content/6/1/41
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post exercise hypotension and recovery second heart
sound lower amplitude, to confirm the capability of the
sensor to mirror diastolic pressure trend.
Limitations of the study
We used intermittent auscultatory methods to determine
exercise and post-exercise blood pressure. These ausculta-
tory methods are prone to sampling error and may pro-
vide inaccurate results. Since diastolic isovolumic
relaxation occurs simultaneously with the physical phe-
nomenon (the abrupt deceleration of the moving aortic
blood mass), that gives rise to the S2 amplitude, the S2
amplitude is an algebraic sum of the myocardial and of
the aortic blood mass effects. Several scenarios can occur
for S2 amplitude. 1 – With constant ventricular relaxation
rate, S2 amplitude is directly related to the diastolic aortic
pressure: 2 – With constant aortic diastolic pressure, S2
amplitude is directly related to the ventricular relaxation
rate. Obviously, sensor measured S2 amplitude, without
ventricular relaxation hemodynamics, cannot sense the
ventricular component of the S2. Further studies in
humans with simultaneous hemodynamic assessment
should be done to address this issue. Another limitation
of the study could arise from the fact that we didn't meas-
ure the split in the second cardiac sound [33,34]. The con-
tinuous wavelet transforms (CWTs) method is capable of
detecting its two components, A2 and P2, allowing there-
fore the measurement of the delay between them. This
delay, called the split, is very important in the diagnosis of
many pathological cases, but it was not the aim of this
study
Characteristics of the population and inducible ischemia
Eight (5%) of the 146 patients had stress induced
ischemia. The low rate of test positivity depends on many
factors. The test indication class was not always I or IIa:
low appropriateness in a high volume laboratory setting
mainly depends on too often repeated tests in the absence
clinical changes [35]. Second, stress test was often per-
formed in young patients with low pre-test probability of
CAD (13 controls and 39 patients with atypical chest pain
and/or systemic hypertension). Third, valvular heart dis-
ease patients (moderate aortic stenosis in 9, moderate
mitral regurgitation in 10) were referred for Doppler stress
echo. Fourth, 17 CAD patients underwent dipyridamole
stress for coronary flow reserve evaluation of left anterior
descending coronary artery [8].
Conclusion
Continuous and non-invasive monitoring of blood pres-
sure (BP) is important to prevent hypertensive patients
from stroke and heart attack. However, most of the preva-
lent BP devices can provide solely intermittent measure-
ments. S2 recording quantitatively documents systemic
pressure changes: S2 amplitude trend is up-sloping when
pressure increases as may occur during physical exercise or
is flat for a flat pressure trend as may occur during dipyri-
damole induced vasodilatation. A new concept of non-
invasive blood pressure measurement by heart sound pat-
tern analysis is described. The known diagnostic criterion
of the 'accentuated' second heart sound of a hypertensive
patient is here converted into a computer-aided pattern-
recognition process for the second heart sound, applicable
over the entire range of blood pressure. The method is in
principle suited for automatically repeated blood pressure
measurements, but further development is still needed for
conversion into a widely practicable procedure. Integrat-
ing first heart sound [1], second heart sound amplitude
and first-second heart sound time delay [3], a cutaneous
operator-independent force sensor describes in real time
systolic elastance, diastolic time, and systemic pressure
trend, offering a new chance to monitor failing hearts.
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